Cytomegalovirus immunisation

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Supportive / diluent 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Moderna Inc. Commercial
    MRNA ENCODING HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B, MRNA ENCODING HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN H, MRNA ENCODING HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN L, MRNA ENCODING HUMAN CYTOMEGALOVIRUS UL128, MRNA ENCODING HUMAN CYTOMEGALOVIRUS UL130, MRNA ENCODING HUMAN CYTOMEGALOVIRUS UL131A; SODIUM CHLORIDE
    2023-508820-37-00 7 countries 2022 n=1,853
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Moderna Inc. Commercial 1 Phase III 0
New trials by year
2022
1
← All indication landscapes